Clinical Trial Update: Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial comparing the fixed-dose combination insulin glargine/lixisenatide to insulin glargine alone, both added to metformin, in type 2 diabetes with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Lixisenatide (lixisenatide)
• Soliqua (insulin glargine/lixisenatide) (insulin glargine/lixisenatide)

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2017-02-10